AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/121
NEW ANTIPLATELET AGENTS FOR ACUTE CORONARY SYNDROMES
Authors: FERGUSON JJ LAU TK
Citation: Jj. Ferguson et Tk. Lau, NEW ANTIPLATELET AGENTS FOR ACUTE CORONARY SYNDROMES, The American heart journal, 135(5), 1998, pp. 194-200
THE EFFECT OF BODY-WEIGHT AND BODY-SURFACE AREA CORRECTION ON THE DISTRIBUTION OF THE ACT RESPONSE TO BOLUS DOSES OF HEPARIN FOR PTCA
Authors: FERGUSON JJ WALY HMF LE D THOMAKOS N WILSON JM
Citation: Jj. Ferguson et al., THE EFFECT OF BODY-WEIGHT AND BODY-SURFACE AREA CORRECTION ON THE DISTRIBUTION OF THE ACT RESPONSE TO BOLUS DOSES OF HEPARIN FOR PTCA, The Journal of invasive cardiology, 10(6), 1998, pp. 318-322
PERCUTANEOUS APPLICATION OF FIBRIN SEALANT TO ACHIEVE HEMOSTASIS FOLLOWING ARTERIAL CATHETERIZATION
Authors: KIPSHIDZE N FERGUSON JJ MACRIS MP CLUBB F CLOY M HORN J SPERL F SAHOTA H KEELAN MH NIKOLAYCHIK V
Citation: N. Kipshidze et al., PERCUTANEOUS APPLICATION OF FIBRIN SEALANT TO ACHIEVE HEMOSTASIS FOLLOWING ARTERIAL CATHETERIZATION, The Journal of invasive cardiology, 10(3), 1998, pp. 133-141
PAPER IN BMJ INFLUENCED PRESCRIBING OF MINOCYCLINE
Authors: FERGUSON JJ JENKINS MGV FIELD J
Citation: Jj. Ferguson et al., PAPER IN BMJ INFLUENCED PRESCRIBING OF MINOCYCLINE, BMJ. British medical journal, 316(7124), 1998, pp. 72-73
INFLUENCE OF INSURANCE TYPE ON THE USE OF PROCEDURES, MEDICATIONS ANDHOSPITAL OUTCOME IN PATIENTS WITH UNSTABLE ANGINA - RESULTS FROM THE GUARANTEE REGISTRY
Authors: EVERY NR CANNON CP GRANGER C MOLITERNO DJ AGUIRRE FV TALLEY JD BOOTH J SAPP S FERGUSON JJ
Citation: Nr. Every et al., INFLUENCE OF INSURANCE TYPE ON THE USE OF PROCEDURES, MEDICATIONS ANDHOSPITAL OUTCOME IN PATIENTS WITH UNSTABLE ANGINA - RESULTS FROM THE GUARANTEE REGISTRY, Journal of the American College of Cardiology, 32(2), 1998, pp. 387-392
SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMSAFETY AND TOLERABILITY RESULTS OF THE SOAR STUDY/
Authors: DEEDWANIA PC FERGUSON JJ KEREIAKES DJ FITZGERALD D ANDERS RJ BURNS DM BRYZINSKI BS
Citation: Pc. Deedwania et al., SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMSAFETY AND TOLERABILITY RESULTS OF THE SOAR STUDY/, Journal of the American College of Cardiology, 31(2), 1998, pp. 94-94
SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMPHARMACODYNAMIC RESULTS OF THE SOAR STUDY/
Authors: FERGUSON JJ DEEDWANIA PC KEREIAKES DJ FITZGERALD D ANDERS RJ BURNS DM BRYZINSKI BS
Citation: Jj. Ferguson et al., SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL ORBOFIBAN - INTERIMPHARMACODYNAMIC RESULTS OF THE SOAR STUDY/, Journal of the American College of Cardiology, 31(2), 1998, pp. 185-185
IMPROVEMENTS IN THE TREATMENT OF ELDERLY PATIENTS WITH UNSTABLE ANGINA - RESULTS FROM THE GUARANTEE REGISTRY
Authors: ROE MT MOLITERNO DJ CANNON CP EVERY NR AGUIRRE FV GRANGER CB SAPP S BOOTH J FERGUSON JJ
Citation: Mt. Roe et al., IMPROVEMENTS IN THE TREATMENT OF ELDERLY PATIENTS WITH UNSTABLE ANGINA - RESULTS FROM THE GUARANTEE REGISTRY, Journal of the American College of Cardiology, 31(2), 1998, pp. 308-308
FUNDAMENTALS OF COAGULATION AND GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITION/
Authors: FERGUSON JJ WALY HM WILSON JM
Citation: Jj. Ferguson et al., FUNDAMENTALS OF COAGULATION AND GLYCOPROTEIN IIB IIIA RECEPTOR INHIBITION/, European heart journal, 19, 1998, pp. 3-9
SAFE USE OF PLATELET GP IIB IIIA INHIBITORS
Authors: FERGUSON JJ KEREIAKES DJ ADGEY AAJ FOX KAA HILLEGASS WB PFISTERER M VASSANELLI C
Citation: Jj. Ferguson et al., SAFE USE OF PLATELET GP IIB IIIA INHIBITORS, European heart journal, 19, 1998, pp. 40-51
SOAR (SAFETY OF ORBOFIBAN IN ACUTE CORONARY RESEARCH)
Authors: FERGUSON JJ
Citation: Jj. Ferguson, SOAR (SAFETY OF ORBOFIBAN IN ACUTE CORONARY RESEARCH), Clinical cardiology, 21(7), 1998, pp. 513-513
ATHEROSCLEROTIC DISEASE - INTRODUCTION
Authors: FERGUSON JJ
Citation: Jj. Ferguson, ATHEROSCLEROTIC DISEASE - INTRODUCTION, Clinical therapeutics, 20, 1998, pp. 1-1
ROUND-TABLE DISCUSSION - CLINICAL SAFETY AND EFFICACY OF CLOPIDOGREL-IMPLICATIONS OF THE CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS (CAPRIE) STUDY FOR FUTURE MANAGEMENT OF ATHEROSCLEROTIC DISEASE
Authors: FERGUSON JJ GONZALEZ ER KANNEL WB OLIN JW RAPS EC
Citation: Jj. Ferguson et al., ROUND-TABLE DISCUSSION - CLINICAL SAFETY AND EFFICACY OF CLOPIDOGREL-IMPLICATIONS OF THE CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS (CAPRIE) STUDY FOR FUTURE MANAGEMENT OF ATHEROSCLEROTIC DISEASE, Clinical therapeutics, 20, 1998, pp. 42-53
EVALUATION OF ENDOTHELIUM-DEPENDENT VASODILATATION IN ORTHOTOPIC HEART-TRANSPLANT PATIENTS
Authors: DIETZ JG CROITORU M HAAS CP FISH D HENDERSON M LIE VV FERGUSON JJ RADOVANCEVIC B
Citation: Jg. Dietz et al., EVALUATION OF ENDOTHELIUM-DEPENDENT VASODILATATION IN ORTHOTOPIC HEART-TRANSPLANT PATIENTS, Circulation, 98(17), 1998, pp. 2872-2872
THE SLOW-FLOW, NO-FLOW PHENOMENA DURING ROTATIONAL ATHERECTOMY - DOESABCIXIMAB HELP
Authors: DIEZ JG FISH D CROITORU M HAAS CP FERGUSON JJ
Citation: Jg. Diez et al., THE SLOW-FLOW, NO-FLOW PHENOMENA DURING ROTATIONAL ATHERECTOMY - DOESABCIXIMAB HELP, Circulation, 98(17), 1998, pp. 2938-2938
SAFETY OF ORBOFIBAN IN ACUTE CORONARY RESEARCH (SOAR) STUDY AFTER 3 MONTHS OF TREATMENT
Authors: THEROUX P DEEDWANIA PC FERGUSON JJ KERELAKES DJ FITZGERALD D BURNS DM ANDERS RJ
Citation: P. Theroux et al., SAFETY OF ORBOFIBAN IN ACUTE CORONARY RESEARCH (SOAR) STUDY AFTER 3 MONTHS OF TREATMENT, Circulation, 98(17), 1998, pp. 4020-4020
THE BENCHMARK COUNTERPULSATION OUTCOMES REGISTRY - INITIAL RESULTS IN3811 PATIENTS
Authors: FERGUSON JJ COHEN M FREEDMAN R GRAEBER GM CUFFEY RR MILLER MF JOSEPH DL
Citation: Jj. Ferguson et al., THE BENCHMARK COUNTERPULSATION OUTCOMES REGISTRY - INITIAL RESULTS IN3811 PATIENTS, Circulation, 98(17), 1998, pp. 4360-4360
PHARMACODYNAMIC EFFICACY, CLINICAL SAFETY, AND OUTCOMES AFTER PROLONGED PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE WITH ORAL XEMILOFIBAN - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED TRIAL/
Authors: KEREIAKES DJ KLEIMAN NS FERGUSON JJ MASUD Z BRODERICK TM ABBOTTSMITH CW RUNYON JP ANDERSON LC ANDERS RJ DREILING RJ HANTSBARGER GL BRYZINSKI B TOPOL EJ
Citation: Dj. Kereiakes et al., PHARMACODYNAMIC EFFICACY, CLINICAL SAFETY, AND OUTCOMES AFTER PROLONGED PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE WITH ORAL XEMILOFIBAN - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED TRIAL/, Circulation, 98(13), 1998, pp. 1268-1278
MEETING HIGHLIGHTS - HIGHLIGHTS OF THE 70TH SCIENTIFIC SESSIONS OF THE AMERICAN-HEART-ASSOCIATION
Authors: FERGUSON JJ
Citation: Jj. Ferguson, MEETING HIGHLIGHTS - HIGHLIGHTS OF THE 70TH SCIENTIFIC SESSIONS OF THE AMERICAN-HEART-ASSOCIATION, Circulation, 97(13), 1998, pp. 1217-1220
COMPLICATIONS ASSOCIATED WITH COMBINED USE OF ABCIXIMAB AND AN INTRACORONARY THROMBOLYTIC AGENT (UROKINASE OR TISSUE-TYPE PLASMINOGEN-ACTIVATOR)
Authors: YARYURA RA ZAQQA M FERGUSON JJ
Citation: Ra. Yaryura et al., COMPLICATIONS ASSOCIATED WITH COMBINED USE OF ABCIXIMAB AND AN INTRACORONARY THROMBOLYTIC AGENT (UROKINASE OR TISSUE-TYPE PLASMINOGEN-ACTIVATOR), The American journal of cardiology, 82(4), 1998, pp. 518
PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE WITH ABCIXIMAB REDUCES ISCHEMIC COMPLICATIONS IN PATIENTS UNDERGOING DIRECTIONAL CORONARY ATHERECTOMY/
Authors: GHAFFARI S KEREIAKES DJ LINCOFF AM KELLY TA TIMMIS GC KLEIMAN NS FERGUSON JJ MILLER DP CALIFF RA TOPOL EJ
Citation: S. Ghaffari et al., PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE WITH ABCIXIMAB REDUCES ISCHEMIC COMPLICATIONS IN PATIENTS UNDERGOING DIRECTIONAL CORONARY ATHERECTOMY/, The American journal of cardiology, 82(1), 1998, pp. 7-12
FUNDAMENTALS OF COAGULATION AND GLYCOPROTEIN-IIB IIIA RECEPTOR INHIBITION/
Authors: FERGUSON JJ WALY HM WILSON JM
Citation: Jj. Ferguson et al., FUNDAMENTALS OF COAGULATION AND GLYCOPROTEIN-IIB IIIA RECEPTOR INHIBITION/, The American heart journal, 135(4), 1998, pp. 35-42
SAFE USE OF PLATELET GP IIB IIIA INHIBITORS
Authors: FERGUSON JJ KEREIAKES DJ ADGEY AAJ FOX KAA HILLEGASS WB PFISTERER M VASSANELLI C
Citation: Jj. Ferguson et al., SAFE USE OF PLATELET GP IIB IIIA INHIBITORS, The American heart journal, 135(4), 1998, pp. 77-89
NEW PHARMACOLOGICAL ADJUNCTS FOR CORONARY STENTING - CAN NEW ANTICOAGULANTS IMPROVE OUTCOMES
Authors: FERGUSON JJ
Citation: Jj. Ferguson, NEW PHARMACOLOGICAL ADJUNCTS FOR CORONARY STENTING - CAN NEW ANTICOAGULANTS IMPROVE OUTCOMES, Journal of interventional cardiology, 10(2), 1997, pp. 155-159
IMPLEMENTATION OF AHCPR GUIDELINES FOR UNSTABLE ANGINA IN 1996 - UNFORTUNATE DIFFERENCES BETWEEN MEN AND WOMEN RESULTS FROM THE MULTICENTERGUARANTEE REGISTRY
Authors: CANNON CP MOLITERNO DJ EVERY N ANDERSON HV AGUIRRE FV GRANGER CB LAMBREW CT RABBANI LE ARNOLD A SCIRICA BM SAPP S BOOTH JE FERGUSON JJ
Citation: Cp. Cannon et al., IMPLEMENTATION OF AHCPR GUIDELINES FOR UNSTABLE ANGINA IN 1996 - UNFORTUNATE DIFFERENCES BETWEEN MEN AND WOMEN RESULTS FROM THE MULTICENTERGUARANTEE REGISTRY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7605-7605
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>